The Utilisation of Marrow Concentrate in Canine Arthrosis—Case Report

The use of bone marrow concentrate in the treatment of degenerative joint disese (DJD) in dogs represents an innovative approach, minim invasive, that already has been used with increasing success in the veterinary field. The technique, adapted from human medicine for the quadruped patients is based on the principle of the autologous transplant of mesenchymal stem cells that are included in the bone marrow concentrate. The intervention involves a short anesthesia of the animal for harvesting the marrow. The processing of the marrow is realised in strict aseptic conditions in a laboratory and the inoculation is done in the same day. The results are clinically visible after 2-4 weeks. For an enhanced effect, a part of the concentrate is grown on a flask in specific conditions in order to expand autologous bone marrow stem cells and is inoculated after a sufficient number of cells are achieved, usually 3-4 weeks.